MedTrace Logo

HBM-Based Intervention on Cancer Screening

NCT07583693 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-13

No results posted yet for this study

Summary

The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not undergo regular screenings. The study will be conducted in two family centers, which will be assigned to intervention and control groups using a lottery method. The intervention group will receive a single-session group education, followed by weekly SMS reminders encouraging screening for two weeks. The control group will receive no additional intervention and will continue with standard care. Data will be collected simultaneously from both groups at three points: before the education, immediately after the education, and one month post-intervention.

Conditions

  • Cancer Screening
  • Health Belief Model
  • Attitude
  • Perception

Interventions

BEHAVIORAL

HBM-Based İntervention on Cancer Screening

The intervention group will receive a single-session group education lasting 45 minutes. The educational session will be supported by visual presentations, demonstrations on anatomical models, question-and-answer sessions, and group discussions. The curriculum covers the importance of early diagnosis and specific screening methods for breast, cervical, and colorectal cancers. Following the session, participants will receive motivational SMS reminders once a week for two consecutive weeks. These text messages will include motivational phrases to encourage screening attendance, as well as phone numbers and links for scheduling free screening appointments.

Sponsors & Collaborators

  • Lokman Hekim University

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-06
Primary Completion
2026-06-06
Completion
2026-06-06

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07583693 on ClinicalTrials.gov